MedTrace Logo

Macrolane for Enhancement of the Shape and Fullness of the Female Breast

NCT01308853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-09-28

Study results available
· View outcomes & findings →

Summary

The study evaluates treatment procedure, efficacy and safety of Macrolane for female breast enhancement.

Conditions

  • Breast Enhancement

Interventions

DEVICE

Macrolane

Device: Macrolane Treatment: Initial injection (incl touch-up) of a maximum of 120 ml/breast.

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Per Heden, M.D. · Akademikliniken, Stockholm, Sweden

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-02-29
Completion
2010-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01308853 on ClinicalTrials.gov